Insights into immunophilin structure and function

Current Medicinal Chemistry

Volumn 18, Issue 35, 2011, Pages 5333-5354

  Lucke C ^a   Weiwad, M ^a  

^a MAX PLANCK RESEARCH UNIT FOR ENZYMOLOGY OF PROTEIN FOLDING   (Germany)

Author keywords

Calcineurin; Cyclophilin; FK506 binding protein; Immunophilin; Immunosuppression; PPIase domain

Indexed keywords

A RAF KINASE; AMINO ACID; CYCLOHEXIMIDE; CYCLOPHILIN; CYCLOSPORIN A; DEXAMETHASONE; GELDANAMYCIN; GLUCOCORTICOID; IMMUNOPHILIN; IMMUNOSUPPRESSIVE AGENT; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5; PEPTIDYLPROLYL ISOMERASE; PROTEIN BCL 2; RAPAMYCIN; RYANODINE RECEPTOR 2; SANGLIFEHRIN A; STEROID RECEPTOR; TACROLIMUS;

BRAIN INJURY; CELL DEATH; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PSITTACI; CIS TRANS ISOMERISM; CRYSTAL STRUCTURE; DEMENTIA; DOPAMINERGIC NERVE CELL; ENZYME STRUCTURE; EX VIVO STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYDROGEN BOND; LONG TERM DEPRESSION; MAMMAL CELL; MITOCHONDRIAL PERMEABILITY; NEOPLASM; NERVE INJURY; NONHUMAN; PARKINSON DISEASE; PROSTATECTOMY; PROTEIN DATA BANK; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; RHEUMATOID ARTHRITIS; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; STREPTOMYCES HYGROSCOPICUS; STROKE; VIRUS INFECTION; XENOBIOTIC METABOLISM;

ANIMALS; BIOCATALYSIS; CATALYTIC DOMAIN; DATABASES, PROTEIN; HUMANS; IMMUNOPHILINS; IMMUNOSUPPRESSIVE AGENTS; ISOMERISM;

EID: 82255195343     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711798194324     Document Type: Review

References (252)

1. Lang, K.; Schmid, F. X.; Fischer, G. Catalysis of protein folding by prolyl isomerase. Nature, 1987, 329, 268-270. (Pubitemid 17128975)
2. Ho, S.; Clipstone, N.; Timmermann, L.; Northrop, J.; Graef, I.; Fiorentino, D.; Nourse, J.; Crabtree, G. R. The mechanism of action of cyclosporin A and FK506. Clin. Immunol. Immunopathol, 1996, 80, S40-S45.
3. Inoki, K.; Ouyang, H.; Li, Y.; Guan, K. L. Signaling by target of rapamycin proteins in cell growth control. Microbiol. Mol. Biol. Rev., 2005, 69, 79-100. (Pubitemid 40358068)
4. Mikol, V.; Kallen, J.; Pflügl, G.; Walkinshaw, M. D. X-ray structure of a monomeric cyclophilin A-cyclosporin A crystal complex at 2.1 Å resolution. J. Mol. Biol, 1993, 234, 1119-1130.
5. Michnick, S. W.; Rosen, M. K.; Wandless, T. J.; Karplus, M.; Schreiber, S. L. Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin. Science, 1991, 252, 836-839. (Pubitemid 121000523)
6. Richardson, J. S. β-Sheet topology and the relatedness of proteins. Nature, 1977, 268, 495-500.
7. Dornan, J.; Taylor, P.; Walkinshaw, M. D. Structures of immunophilins and their ligand complexes. Curr. Top. Med. Chem., 2003, 3, 1392-1409.
8. Galat, A. Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity - targets - functions. Curr. Top. Med. Chem., 2003, 3, 1315-1347.
9. Wüthrich, K.; von Freyberg, B.; Weber, C.; Wider, G.; Traber, R.; Widmer, H.; Braun, W. Receptor-induced conformation change of the immunosuppressant cyclosporin A. Science, 1991, 254, 953-954.
10. 15N NMR relaxation studies of the FK506 binding protein: dynamic effects of ligand binding and implications for calcineurin recognition. Biochemistry, 1994, 33, 4093-4100.
11. Griffith, J. P.; Kim, J. L.; Kim, E. E.; Sintchak, M. D.; Thomson, J. A.; Fitzgibbon, M. J.; Fleming, M. A.; Caron, P. R.; Hsiao, K.; Navia, M. A. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell, 1995, 82, 507-522.
12. Huai, Q.; Kim, H. Y.; Liu, Y.; Zhao, Y.; Mondragon, A.; Liu, J. O.; Ke, H. Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 12037-12042.
13. Galat, A.; Bua, J. Molecular aspects of cyclophilins mediating therapeutic actions of their ligands. Cell. Mol. Life Sci., 2010, 67, 3467-3488.
14. Saul, FA.; Arié, J. P.; Vulliez-le Normand, B.; Kahn, R.; Betton, J. M.; Bentley, G. A. Structural and functional studies of FkpA from Escherichia coli, a cis/trans peptidyl-prolyl isomerase with chaperone activity. J. Mol. Biol, 2004, 335, 595-608. (Pubitemid 37532659)
15. Suzuki, R.; Nagata, K.; Yumoto, F.; Kawakami, M.; Nemoto, N.; Furutani, M.; Adachi, K.; Maruyama, T.; Tanokura, M. Three-dimensional solution structure of an archaeal FKBP with a dual function of peptidyl prolyl cistrans isomerase and chaperone-like activities. J. Mol. Biol, 2003, 328, 1149-1160. (Pubitemid 36506880)
16. Wilson, K. P.; Yamashita, MM.; Sintchak, M. D.; Rotstein, S. H.; Murcko, M. A.; Boger, J.; Thomson, J. A.; Fitzgibbon, M. J.; Black, J. R.; Navia, M. A. Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unliganded form and in complex with FK506 and rapamycin. Acta Crystallogr. D Biol. Crystallogr, 1995, 51, 511-521.
17. Schultz, L. W.; Clardy, J. Chemical inducers of dimerization: the atomic structure of FKBP12-FK1012A-FKBP12. Bioorg. Med. Chem. Lett, 1998, 8, 1-6. (Pubitemid 28021683)
18. Itoh, S.; DeCenzo, M. T.; Livingston, D. J.; Pearlman, D. A.; Navia, M. A. Conformation of FK506 in X-ray structures of its complexes with human recombinant FKBP12 mutants. Bioorg. Med. Chem. Lett, 1995, 5, 1983-1988.
19. Clackson, T.; Yang, W.; Rozamus, L. W.; Hatada, M.; Amara, J. F.; Rollins, C. T.; Stevenson, L. F.; Magari, S. R.; Wood, S. A.; Courage, N. L.; Lu, X.; Cerasoli, F. Jr.; Gilman, M.; Holt, D. A. Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. Proc. Natl. Acad. Sci. U. S. A., 1998, 95, 10437-10442. (Pubitemid 28413085)
20. Burkhard, P.; Taylor, P.; Walkinshaw, M. D. X-ray structures of small ligand-FKBP complexes provide an estimate for hydrophobic interaction energies. J. Mol. Biol, 2000, 295, 953-962.
21. Sich, C.; Improta, S.; Cowley, D. J.; Guenet, C.; Merly, J. P.; Teufel, M.; Saudek, V. Solution structure of a neurotrophic ligand bound to FKBP12 and its effects on protein dynamics. Eur. J. Biochem., 2000, 267, 5342-5355.
22. Choi, J.; Chen, J.; Schreiber, S. L.; Clardy, J. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science, 1996, 273, 239-242. (Pubitemid 26285890)
23. Van Duyne, G. D.; Standaert, R. F.; Schreiber, S. L.; Clardy, J. Atomic structure of the rapamycin human immunophilin FKBP-12 complex. J. Am. Chem. Soc, 1991, 113, 7433-7434.
24. Holt, D. A.; Luengo, J. I.; Yamashita, D. S.; Oh, H. J.; Konialian, A. L.; Yen, H. K.; Rozamus, L. W.; Brandt, M.; Bossard, M. J.; Levy, M. A.; Eggleston, D. S.; Liang, J.; Schultz, L. W.; Stout, T. J.; Clardy, J. Design, synthesis, and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structures of their complexes with FKBP12. J. Am. Chem. Soc, 1993, 115, 9925-9938.
25. Dubowchik, GM.; Vrudhula, V. M.; Dasgupta, B.; Ditta, J.; Chen, T.; Sheriff, S.; Sipman, K.; Witmer, M.; Tredup, J.; Vyas, DM.; Verdoorn, T. A.; Bollini, S.; Vinitsky, A. 2-Aryl-2, 2-difluoroacetamide FKBP12 ligands: synthesis and X-ray structural studies. Org. Lett, 2001, 3, 3987-3990. (Pubitemid 33629522)
26. Liang, J.; Choi, J.; Clardy, J. Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 Å resolution. Acta Crystallogr. D Biol. Crystallogr, 1999, 55, 736-744. (Pubitemid 29194519)
27. Fulton, K. F.; Jackson, S. E.; Buckle, A. M. Energetic and structural analysis of the role of tryptophan 59 in FKBP12. Biochemistry, 2003, 42, 2364-2372. (Pubitemid 36255210)
28. Szep, S.; Park, S.; Boder, E. T.; Van Duyne, G. D.; Saven, J. G. Structural coupling between FKBP12 and buried water. Proteins, 2009, 74, 603-611.
29. Huse, M.; Chen, Y. G.; Massagué, J.; Kuriyan, J. Crystal structure of the cytoplasmic domain of the type I TGF β receptor in complex with FKBP12. Cell, 1999, 96, 425-436. (Pubitemid 29077596)
30. Rollins, C. T.; Rivera, V. M.; Woolfson, D. N.; Keenan, T.; Hatada, M.; Adams, S. E.; Andrade, L. J.; Yaeger, D.; van Schravendijk, M. R.; Holt, D. A.; Gilman, M.; Clackson, T. A ligand-reversible dimerization system for controlling protein-protein interactions. Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 7096-7101. (Pubitemid 30431423)
31. Becker, J. W.; Rotonda, J.; McKeever, B. M.; Chan, H. K.; Marcy, A. I.; Wiederrecht, G.; Hermes, J. D.; Springer, J. P. FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685, 818. J. Biol. Chem., 1993, 268, 11335-11339. (Pubitemid 23162330)
32. Sun, F.; Li, P.; Ding, Y.; Wang, L.; Bartlam, M.; Shu, C.; Shen, B.; Jiang, H.; Li, S.; Rao, Z. Design and structure-based study of new potential FKBP12 inhibitors. Biophys. J., 2003, 85, 3194-3201. (Pubitemid 37345806)
33. Becker, J. W.; Rotonda, J.; Cryan, J. G.; Martin, M.; Parsons, W. H.; Sinclair, P. J.; Wiederrecht, G.; Wong, F. 32-Indolyl ether derivatives of ascomycin: three-dimensional structures of complexes with FK506-binding protein. J. Med. Chem., 1999, 42, 2798-2804. (Pubitemid 29370424)
34. Rotonda, J.; Burbaum, J. J.; Chan, H. K.; Marcy, A. I.; Becker, J. W. Improved calcineurin inhibition by yeast FKBP12-drug complexes. Crystallographic and functional analysis. J. Biol. Chem., 1993, 268, 7607-7609. (Pubitemid 23120320)
35. Deivanayagam, C. C.; Carson, M.; Thotakura, A.; Narayana, S. V.; Chodavarapu, R. S. Structure of FKBP12.6 in complex with rapamycin. Acta Crystallogr. D Biol. Crystallogr, 2000, 56, 266-271. (Pubitemid 30147176)
36. Gopalan, G.; He, Z.; Balmer, Y.; Romano, P.; Gupta, R.; Héroux, A.; Buchanan, B. B.; Swaminathan, K.; Luan, S. Structural analysis uncovers a role for redox in regulating FKBP13, an immunophilin of the chloroplast thylakoid lumen. Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 13945-13950. (Pubitemid 39298512)
37. Liang, J.; Hung, D. T.; Schreiber, S. L.; Clardy, J. Structure of the human 25 kDa FK506 binding protein complexed with rapamycin. J. Am. Chem. Soc, 1996, 118, 1231-1232. (Pubitemid 26075553)
38. Riboldi-Tunnicliffe, A.; König, B.; Jessen, S.; Weiss, M. S.; Rahfeld, J.; Hacker, J.; Fischer, G.; Hilgenfeld, R. Crystal structure of Mip, a prolylisomerase from Legionella pneumophila. Nat. Struct. Biol, 2001, 8, 779-783. (Pubitemid 32803596)
39. Horstmann, M.; Ehses, P.; Schweimer, K.; Steinert, M.; Kamphausen, T.; Fischer, G.; Hacker, J.; Rösch, P.; Faber, C. Domain motions of the Mip protein from Legionella pneumophila. Biochemistry, 2006, 45, 12303-12311. (Pubitemid 44527553)
40. Ceymann, A.; Horstmann, M.; Ehses, P.; Schweimer, K.; Paschke, A. K.; Steinert, M.; Faber, C. Solution structure of the Legionella pneumophila Mip-rapamycin complex. BMC Struct. Biol, 2008, 8, 17.
41. Pereira, P. J.; Vega, M. C.; González-Rey, E.; Fernández-Carazo, R.; Macedo-Ribeiro, S.; Gomis-Rüth, F. X.; González, A.; Coll, M. Trypanosoma cruzi macrophage infectivity potentiator has a rotamase core and a highly exposed α-helix. EMBO Rep., 2002, 3, 88-94. (Pubitemid 34144821)
42. Alag, R.; Bharatham, N.; Dong, A.; Hills, T.; Harikishore, A.; Widjaja, A. A.; Shochat, S. G.; Hui, R.; Yoon, H. S. Crystallographic structure of the tetratricopeptide repeat domain of Plasmodium falciparum FKBP35 and its molecular interaction with Hsp90 C-terminal pentapeptide. Protein Sci., 2009, 18, 2115-2124.
43. Kotaka, M.; Ye, H.; Alag, R.; Hu, G.; Bozdech, Z.; Preiser, P. R.; Yoon, H. S.; Lescar, J. Crystal structure of the FK506 binding domain of Plasmodium falciparum FKBP35 in complex with FK506. Biochemistry, 2008, 47, 5951-5961. (Pubitemid 351770025)
44. Kang, C. B.; Ye, H.; Yoon, H. R.; Yoon, H. S. Solution structure of FK506 binding domain (FKBD) of Plasmodium falciparum FK506 binding protein 35 (PfFKBP35). Proteins, 2008, 70, 300-302. (Pubitemid 350293473)
45. Alag, R.; Shin, J.; Yoon, H. S. NMR assignments of the FK506-binding domain of FK506-binding protein 35 from Plasmodium vivax. Biomol. NMR Assign., 2009, 3, 243-245.
46. Alag, R.; Qureshi, I. A.; Bharatham, N.; Shin, J.; Lescar, J.; Yoon, H. S. NMR and crystallographic structures of the FK506 binding domain of human malarial parasite Plasmodium vivax FKBP35. Protein Sci., 2010, 19, 1577-1586.
47. Maestre-Martínez, M.; Haupt, K.; Edlich, F.; Neumann, P.; Parthier, C.; Stubbs, M. T.; Fischer, G.; Lücke, C. A charge-sensitive loop in the FKBP38 catalytic domain modulates Bcl-2 binding. J. Mol. Recognit., 2011, 24, 23-34.
48. Maestre-Martínez, M.; Edlich, F.; Jarczowski, F.; Weiwad, M.; Fischer, G.; Lücke, C. Solution structure of the FK506-binding domain of human FKBP38. J. Biomol. NMR, 2006, 34, 197-202.
49. Weiergräber, O. H.; Eckhoff, A.; Granzin, J. Crystal structure of a plant immunophilin domain involved in regulation of MDR-type ABC transporters. FEBS Lett., 2006, 580, 251-255. (Pubitemid 43005345)
50. Granzin, J.; Eckhoff, A.; Weiergräber, O. H. Crystal structure of a multidomain immunophilin from Arabidopsis thaliana: a paradigm for regulation of plant ABC transporters. J. Mol. Biol., 2006, 364, 799-809. (Pubitemid 44755319)
51. Sinars, C. R.; Cheung-Flynn, J.; Rimerman, R. A.; Scammell, J. G.; Smith, D. F.; Clardy, J. Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Proc. Natl. Acad. Sci. U. S. A., 2003, 100, 868-873. (Pubitemid 36183922)
52. Li, P.; Ding, Y.; Wu, B.; Shu, C.; Shen, B.; Rao, Z. Structure of the N-terminal domain of human FKBP52. Acta Crystallogr. D Biol. Crystallogr., 2003, 59, 16-22. (Pubitemid 36117201)
53. Wu, B.; Li, P.; Liu, Y.; Lou, Z.; Ding, Y.; Shu, C.; Ye, S.; Bartlam, M.; Shen, B.; Rao, Z. 3D structure of human FK506-binding protein 52: implications for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex. Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 8348-8353. (Pubitemid 38736578)
54. Craescu, C. T.; Rouvière, N.; Popescu, A.; Cerpolini, E.; Lebeau, M. C.; Baulieu, E. E.; Mispelter, J. Three-dimensional structure of the immunophilin-like domain of FKBP59 in solution. Biochemistry, 1996, 35, 11045-11052. (Pubitemid 26298737)
55. Unger, T.; Dym, O.; Albeck, S.; Jacobovitch, Y.; Bernehim, R.; Marom, D.; Pisanty, O.; Breiman, A. Crystal structure of the three FK506 binding protein domains of wheat FKBP73: evidence for a unique wFK73-2 domain. J. Struct. Funct. Genomics, 2010, 11, 113-123.
56. Weininger, U.; Haupt, C.; Schweimer, K.; Graubner, W.; Kovermann, M.; Brüser, T.; Scholz, C.; Schaarschmidt, P.; Zoldak, G.; Schmid, F. X.; Balbach, J. NMR solution structure of SlyD from Escherichia coli: spatial separation of prolyl isomerase and chaperone function. J. Mol. Biol., 2009, 387, 295-305.
57. Martino, L.; He, Y.; Hands-Taylor, K. L.; Valentine, E. R.; Kelly, G.; Giancola, C.; Conte, M. R. The interaction of the Escherichia coli protein SlyD with nickel ions illuminates the mechanism of regulation of its peptidyl-prolyl isomerase activity. FEBS J., 2009, 276, 4529-4544.
58. Löw, C.; Neumann, P.; Tidow, H.; Weininger, U.; Haupt, C.; Friedrich-Epler, B.; Scholz, C.; Stubbs, M. T.; Balbach, J. Crystal structure determination and functional characterization of the metallochaperone SlyD from Thermus thermophilus. J. Mol. Biol., 2010, 398, 375-390.
59. Vogtherr, M.; Jacobs, D. M.; Parac, T. N.; Maurer, M.; Pahl, A.; Saxena, K.; Rüterjans, H.; Griesinger, C.; Fiebig, K. M. NMR solution structure and dynamics of the peptidyl-prolyl cis-trans isomerase domain of the trigger factor from Mycoplasma genitalium compared to FK506-binding protein. J. Mol. Biol., 2002, 318, 1097-1115. (Pubitemid 35012023)
60. Kay, J. E. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases. Biochem. J., 1996, 314, 361-385.
61. 2+/calmodulin. EMBO J., 2005, 24, 2688-2699. (Pubitemid 41076324)
62. Brecht, S.; Schwarze, K.; Waetzig, V.; Christner, C.; Heiland, S.; Fischer, G.; Sartor, K.; Herdegen, T. Changes in peptidyl-prolyl cis/trans isomerase activity and FK506 binding protein expression following neuroprotection by FK506 in the ischemic rat brain. Neuroscience, 2003, 120, 1037-1048. (Pubitemid 36966654)
63. Christner, C.; Herdegen, T.; Fischer, G. FKBP ligands as novel therapeutics for neurological disorders. Mini-Rev. Med. Chem., 2001, 1, 377-397.
64. Gold, B. G. FK506 and the role of immunophilins in nerve regeneration. Mol. Neurobiol., 1997, 15, 285-306. (Pubitemid 127720199)
65. Hamilton, G. S.; Huang, W.; Connolly, M. A.; Ross, D. T.; Guo, H.; Valentine, H. L.; Suzdak, P. D.; Steiner, J. P. FKBP12-binding domain analogues of FK506 are potent, nonimmunosuppressive neurotrophic agents in vitro and promote recovery in a mouse model of parkinson's disease. Bioorg. Med. Chem. Lett., 1997, 7, 1785-1790. (Pubitemid 27321504)
66. Steiner, J. P.; Connolly, M. A.; Valentine, H. I.; Hamilton, G. S.; Dawson, T. M.; Hester, L.; Snyder, S. H. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat. Med., 1997, 3, 421-428. (Pubitemid 27145684)
67. Alemdar, A. Y.; Baker, K. A.; Sadi, D.; McAlister, V. C.; Mendez, I. Liposomal tacrolimus administered systemically and within the donor cell suspension improves xenograft survival in hemiparkinsonian rats. Exp. Neurol, 2001, 172, 416-424. (Pubitemid 34075090)
68. Guo, X.; Dawson, V. L.; Dawson, T. M. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. Eur. J. Neurosci., 2001, 13, 1683-1693. (Pubitemid 32488058)
69. Mogi, M.; Togari, A.; Tanaka, K.; Ogawa, N.; Ichinose, H.; Nagatsu, T. Increase in level of tumor necrosis factor-α in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosuppressant FK506. Neurosci. Lett, 2000, 289, 165-168. (Pubitemid 30657964)
70. Sharkey, J.; Butcher, S. P. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature, 1994, 371, 336-339. (Pubitemid 24300615)
71. Hodgkiss, J. P.; Kelly, J. S. Only 'de novo' long-term depression (LTD) in the rat hippocampus in vitro is blocked by the same low concentration of FK506 that blocks LTD in the visual cortex. Brain Res., 1995, 705, 241-246. (Pubitemid 26037369)
72. Funauchi, M.; Haruta, H.; Tsumoto, T. Effects of an inhibitor for c alc ium/calmodulin-dependent protein phosphatase, calcineurin, on induction of long-term potentiation in rat visual cortex. Neurosci. Res., 1994, 19, 269-278. (Pubitemid 24146906)
73. Tong, G.; Shepherd, D.; Jahr, C. E. Synaptic desensitization of NMDA receptors by calcineurin. Science, 1995, 267, 1510-1512.
74. Steiner, J. P.; Dawson, T. M.; Fotuhi, M.; Snyder, S. H. Immunophilin regulation of neurotransmitter release. Mol. Med., 1996, 2, 325-333. (Pubitemid 26265082)
75. Dawson, T. M.; Steiner, J. P.; Dawson, V. L.; Dinerman, J. L.; Uhl; G. R.; Snyder, S. H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl. Acad. Sci. U. S. A., 1993, 90, 9808-9812. (Pubitemid 23328199)
76. Sezen, S. F.; Hoke, A.; Burnett, A. L.; Snyder, S. H. Immunophilin ligand FK506 is neuroprotective for penile innervation. Nat. Med, 2001, 7, 1073-1074. (Pubitemid 33009995)
77. Burnett, A. L.; Becker, R. E. Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury. J. Urol, 2004, 171, 495-500. (Pubitemid 37549218)
78. Avramut, M.; Achim, C. L. Immunophilins in nervous system degeneration and regeneration. Curr. Top. Med. Chem., 2003, 3, 1376-1382.
79. Lyons, W. E.; George, E. B.; Dawson, T. M.; Steiner, J. P.; Snyder, S. H. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc. Natl. Acad. Sci. U. S. A., 1994, 91, 3191-3195. (Pubitemid 24130201)
80. Hamilton, G. S.; Steiner, J. P. Immunophilins: beyond immunosuppression. J. Med. Chem., 1998, 41, 5119-5143. (Pubitemid 29016306)
81. Costantini, L. C.; Chaturvedi, P.; Armistead, D. M.; McCaffrey, P. G.; Deacon, T. W.; Isacson, O. A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease. Neurobiol. Dis., 1998, 5, 97-106. (Pubitemid 28430720)
82. Christner, C.; Wyrwa, R.; Marsch, S.; Küllertz, G.; Thiericke, R.; Grabley, S.; Schumann, D.; Fischer, G. Synthesis and cytotoxic evaluation of cycloheximide derivatives as potential inhibitors of FKBP12 with neuroregenerative properties. J. Med. Chem., 1999, 42, 3615-3622. (Pubitemid 29445094)
83. Edlich, F.; Weiwad, M.; Wildemann, D.; Jarczowski, F.; Kilka, S.; Moutty, M. C.; Jahreis, G.; Lücke, C.; Schmidt, W.; Striggow, F.; Fischer, G. The specific FKBP38 inhibitor N-(N', N'-dimethylcarboxamidomethyl) cycloheximide has potent neuroprotective and neurotrophic properties in brain ischemia. J. Biol. Chem., 2006, 281, 14961-14970. (Pubitemid 43855200)
84. Gold, B. G.; Densmore, V.; Shou, W.; Matzuk, MM.; Gordon, H. S. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J. Pharmacol. Exp. Ther, 1999, 289, 1202-1210. (Pubitemid 29246645)
85. Price, R. D.; Yamaji, T.; Matsuoka, N. FK506 potentiates NGF-induced neurite outgrowth via the Ras/Raf/MAP kinase pathway. Br. J. Pharmacol, 2003, 140, 825-829. (Pubitemid 37464063)
86. Price, R. D.; Yamaji, T.; Yamamoto, H.; Higashi, Y.; Hanaoka, K.; Yamazaki, S.; Ishiye, M.; Aramori, I.; Matsuoka, N.; Mutoh, S.; Yanagihara, T.; Gold, B. G. FK1706, a novel non-immunosuppressive immunophilin: neurotrophic activity and mechanism of action. Eur. J. Pharmacol, 2005, 509, 11-19. (Pubitemid 40248780)
87. Ahearn, I. M.; Tsai, F. D.; Court, H.; Zhou, M.; Jennings, B. C.; Ahmed, M.; Fehrenbacher, N.; Linder, M. E.; Philips, M. R. FKBP12 binds to acylated H-ras and promotes depalmitoylation. Mol Cell, 2011, 41, 173-185.
88. Bai, X.; Ma, D.; Liu, A.; Shen, X.; Wang, Q. J.; Liu, Y.; Jiang Y Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science, 2007, 318, 977-980. (Pubitemid 350098994)
89. Hay, N.; Sonenberg, N. Upstream and downstream of mTOR. Genes Dev, 2004, 18, 1926-1945. (Pubitemid 39071573)
90. Gerard, M.; Debyser, Z.; Desender, L.; Kahle, P. J.; Baert, J.; Baekelandt, V.; Engelborghs, Y The aggregation of alpha-synuclein is stimulated by FK506 binding proteins as shown by fluorescence correlation spectroscopy. FASEB J., 2006, 20, 524-526. (Pubitemid 46671237)
91. Gerard, M.; Debyser, Z.; Desender, L.; Baert, J.; Brandt, I.; Baekelandt, V.; Engelborghs, Y. FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T. J. Neurochem., 2008, 106, 121-133. (Pubitemid 351840195)
92. Gerard, M.; Deleersnijder, A.; Daniëls, V.; Schreurs, S.; Munck, S.; Reumers, V.; Pottel, H.; Engelborghs, Y.; Van den Haute, C.; Taymans, J. M.; Debyser, Z.; Baekelandt, V. Inhibition of FK506 binding proteins reduces α-synuclein aggregation and Parkinson's disease-like pathology. J. Neurosci., 2010, 30, 2454-2463.
93. Yamamoto, K. R. Steroid receptor regulated transcription of specific genes and gene networks. Annu. Rev. Genet, 1985, 19, 209-252.
94. Evans, RM. The steroid and thyroid hormone receptor superfamily. Science, 1988, 240, 889-895.
95. Cheung, J.; Smith, D. F. Molecular chaperone interactions with steroid receptors: an update. Mol. Endocrinol., 2000, 14, 939-946. (Pubitemid 32250512)
96. Nair, S. C.; Rimerman, R. A.; Toran, E. J.; Chen, S.; Prapapanich, V.; Butts, R. N.; Smith, D. F. Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor. Mol. Cell. Biol., 1997, 17, 594-603. (Pubitemid 27044358)
97. Barent, R. L.; Nair, S. C.; Carr, D. C.; Ruan, Y.; Rimerman, R. A.; Fulton, J.; Zhang, Y.; Smith, D. F. Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes. Mol. Endocrinol., 1998, 12, 342-354. (Pubitemid 30666265)
98. Reynolds, P. D.; Ruan, Y.; Smith, D. F.; Scammell, J. G. Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J. Clin. Endocrinol. Metab., 1999, 84, 663-669. (Pubitemid 29075703)
99. Scammell, J. G. Steroid resistance in the squirrel monkey: an old subject revisited. ILAR J., 2000, 41, 19-25.
100. Denny, W. B.; Valentine, D. L.; Reynolds, P. D.; Smith, D. F.; Scammell, J. G. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology, 2000, 141, 4107-4113.
101. Baughman, G.; Wiederrecht, G. J.; Campbell, N. F.; Martin, MM.; Bourgeois, S. FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. Mol. Cell. Biol., 1995, 15, 4395-4402.
102. Hubler, T. R.; Denny, W. B.; Valentine, D. L.; Cheung-Flynn, J.; Smith, D. F.; Scammell, J. G. The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. Endocrinology, 2003, 144, 2380-2387. (Pubitemid 36629888)
103. Czar, M. J.; Owensgrillo, J. K.; Yem, A. W.; Leach, K. L.; Deibel, M. R.; Welsh, M. J.; Pratt, W. B. The Hsp56 immunophilin component of untransformed steroid receptor complexes is localized both to microtubules in the cytoplasm and to the same nonrandom regions within the nucleus as the steroid receptor. Mol. Endocrinol., 1994, 8, 1731-1741.
104. Galigniana, M. D.; Harrell, J. M.; O'Hagen, H. M.; Ljungman, M.; Pratt, W. B. Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus. J. Biol. Chem., 2004, 279, 22483-22489. (Pubitemid 38679447)
105. Chen, H.; Yong, W.; Hinds, T. D. Jr.; Yang, Z.; Zhou, Y.; Sanchez, E. R.; Shou, W. Fkbp52 regulates androgen receptor transactivation activity and male urethra morphogenesis. J. Biol. Chem., 2010, 285, 27776-27784.
106. Yong, W.; Yang, Z.; Periyasamy, S.; Chen, H.; Yucel, S.; Li, W.; Lin, L. Y.; Wolf, I. M.; Cohn, M. J.; Baskin, L. S.; Sánchez, E. R.; Shou, W. Essential role for co-chaperone FKBP52 but not FKBP51 in androgen receptor-mediated signaling and physiology. J. Biol. Chem., 2007, 282, 5026-5036. (Pubitemid 47100995)
107. Binder, E. B.; Salyakina, D.; Lichtner, P.; Wochnik, G. M.; Ising, M.; Pütz, B.; Papiol, S.; Seaman, S.; Lucae, S.; Kohli, M. A.; Nickel, T.; Künzel, H. E.; Fuchs, B.; Majer, M.; Pfennig, A.; Kern, N.; Brunner, J.; Modell, S.; Baghai, T.; Deiml, T.; Zill, P.; Bondy, B.; Rupprecht, R.; Messer, T.; Köhnlein, O.; Dabitz, H.; Brückl, T; Müller, N; Pfister, H.; Lieb, R.; Mueller, J. C.; Lãhmussaar, E.; Strom, T. M.; Bettecken, T; Meitinger, T.; Uhr, M.; Rein, T.; Holsboer, F.; Muller-Myhsok, B. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet, 2004, 36, 1319-1325. (Pubitemid 39577942)
108. Jayaraman, T.; Brillantes, A. M.; Timerman, A. P.; Fleischer, S.; Erdjument-Bromage, H.; Tempst, P.; Marks, A. R. FK506 binding protein associated with the calcium release channel (ryanodine receptor). J. Biol. Chem., 1992, 267, 9474-9477.
109. Marx, S. O.; Reiken, S.; Hisamatsu, Y.; Jayaraman, T.; Burkhoff, D.; Rosemblit, N.; Marks, A. R. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell, 2000, 101, 365-376.
110. Marks, A. R. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. J. Mol. Cell. Cardiol., 2001, 33, 615-624. (Pubitemid 32538975)
111. Wehrens, X. H. T.; Lehnart, S. E.; Huang, F.; Vest, J. A.; Reiken, S. R.; Mohler, P. J.; Sun, J.; Guatimosim, S.; Song, L. S.; Rosemblit, N.; D'Armiento, J. M.; Napolitano, C.; Memmi, M.; Priori, S. G.; Lederer, W. J.; Marks, A. R. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell, 2003, 113, 829-840. (Pubitemid 36792028)
112. 2+ release channels: does diversity in form equal diversity in function? Physiol. Rev., 1996, 76, 1027-1071. (Pubitemid 26346815)
113. 2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol. Rev, 1997, 49, 1-51.
114. 2+-release channel function. Biochem. J., 1999, 337, 345-361
115. Ahern, G.; Junankar, P.; Dulhunty, A. Subconductance states in singlechannel activity of skeletal muscle ryanodine receptors after removal of FKBP12. Biophys. J., 1997, 72, 146-162. (Pubitemid 27043425)
116. Timerman, A. P.; Ogunbumni, E.; Freund, E.; Wiederrecht, G.; Marks, A. R.; Fleischer, S. The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. Dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem., 1993, 268, 22992-22999. (Pubitemid 23328003)
117. 2+ leak from the sarcoplasmic reticulum and increases contractility. Circ. Res., 2001, 88, 188-194. (Pubitemid 32147307)
118. 2+ release channels (ryanodine receptors). Science, 1998, 281, 818-821. (Pubitemid 28376041)
119. Avila, G.; Lee, E.; Perez, C.; Allen, P.; Dirksen, R. FKBP12 binding to RyR1 modulates excitation-contraction coupling in mouse skeletal myotubes. J. Biol. Chem., 2003, 278, 22600-22608. (Pubitemid 36830317)
120. 2+ flux. Cell, 1995, 83, 463-472.
121. Jeyakumar, L. H.; Ballester, L.; Cheng, D. S.; McIntyre, J. O.; Chang, P.; Olivey, H. E.; Rollins-Smith, L.; Barnett, J. V.; Murray, K.; Xin, H. B.; Fleischer, S. FKBP binding characteristics of cardiac microsomes from diverse vertebrates. Biochem. Biophys. Res. Commun., 2001, 281, 979-986. (Pubitemid 32923058)
122. Marks, A. R. Cellular function of immunophilins. Physiol. Rev., 1996, 76, 631-649.
123. Reiken, S.; Lacampagne, A.; Zhou, H.; Kherani, A.; Lehnart, S. E.; Ward, C.; Huang, F.; Gaburjakova, M.; Gaburjakova, J.; Rosemblit, N.; Warren, M. S.; He, K. L.; Yi, G. H.; Wang, J.; Burkhoff, D.; Vassort, G.; Marks, A. R. PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure. J. Cell Biol., 2003, 160, 919-928. (Pubitemid 36350846)
124. Tiso, N.; Salamon, M.; Bagattin, A.; Danieli, G. A.; Argenton, F.; Bortolussi, M. The binding of the RyR2 calcium channel to its gating protein FKBP12.6 is oppositely affected by ARVD2 and VTSIP mutations. Biochem. Biophys. Res. Commun., 2002, 299, 594-598. (Pubitemid 36034587)
125. Lahvis, G. P.; Lindell, S. L.; Thomas, R. S.; McCuskey, R. S.; Murphy, C.; Glover, E.; Bentz, M.; Southard, J.; Bradfield, C. A. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 10442-10447.
126. Veldhoen, M.; Hirota, K.; Westendorf, A. M.; Buer, J.; Dumoutier, L.; Renauld, J. C.; Stockinger, B. The aryl hydrocarbon receptor links TH17-cellmediated autoimmunity to environmental toxins. Nature, 2008, 453, 106-109. (Pubitemid 351630329)
127. Ma, Q.; Whitlock, J. P. Jr. A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem., 1997, 272, 8878-8884. (Pubitemid 27154882)
128. Petrulis, J. R.; Perdew, G. H. The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem.-Biol. Interact., 2002, 141, 25-40. (Pubitemid 35223203)
129. Meyer, B. K.; Pray-Grant, M. G.; Vanden Heuvel, J. P.; Perdew, G. H. Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Mol. Cell. Biol., 1998, 18, 978-988. (Pubitemid 28063432)
130. Kazlauskas, A.; Poellinger, L.; Pongratz, I. The immunophilin-like protein XAP2 regulates ubiquitination and subcellular localization of the dioxin receptor. J. Biol. Chem., 2000, 275, 41317-41324. (Pubitemid 32063008)
131. Hacker, J.; Fischer, G. Immunophilins: structure-function relationship and possible role in microbial pathogenicity. Mol. Microbiol., 1993, 10, 445-456. (Pubitemid 23334426)
132. Rockey, D. D.; Chesebro, B. B.; Heinzen, R. A.; Hackstadt, T. A 28 kDa major immunogen of Chlamydia psittaci shares identity with Mip proteins of Legionella spp. and Chlamydia trachomatis-cloning and characterization of the C. psittaci mip-like gene. Microbiology, 1996, 142, 945-953.
133. Lundemose, A. G.; Birkelund, S.; Fey, S. J.; Larsen, P. M.; Christiansen, G. Chlamydia trachomatis contains a protein similar to the Legionella pneumophila mip gene product. Mol. Microbiol., 1991, 5, 109-115. (Pubitemid 21895946)
134. Mo, Y. Y.; Cianciotto, N. P.; Mallavia, L. P. Molecular cloning of a Coxiella burnetii gene encoding a macrophage infectivity potentiator (Mip) analogue. Microbiology, 1995, 141, 2861-2871.
135. Moro, A.; Ruiz-Cabello, F.; Fernandez-Cano, A.; Stock, R. B.; Gonzales, A. Secretion by Trypanosoma cruzi of a peptidyl-prolyl cis-trans isomerase involved in cell infection. EMBO J., 1995, 14, 2483-2490.
136. Horne, S. M.; Young, K. D. Escherichia coli and other species of the Enterobacteriaceae encode a protein similar to the family of Mip-like FK506-binding proteins. Arch. Microbiol., 1995, 163, 357-365.
137. Cianciotto, N. P.; Eisenstein, B. I.; Mody, C. H.; Toews, G. B.; Engleberg, N. C. A Legionella pneumophila gene encoding a species-specific surface protein potentiates initiation of intracellular infection. Infect. Immun., 1989, 57, 1255-1262. (Pubitemid 19087875)
138. Schmidt, B.; Rahfeld, J.; Schierhorn, A.; Ludwig, B.; Hacker, J.; Fischer, G. A homodimer represents an active species of the peptidyl-prolyl cis/trans isomerase FKBP25mem from Legionella pneumophila. FEBS Lett., 1994, 352, 185-190.
139. Schmidt, B.; König, S.; Svergun, D.; Volkov, V.; Fischer, G.; Koch, M. H. J. Small-angle X-ray solution scattering study on the dimerisation of the FKBP25mem from Legionella pneumophila. FEBS Lett., 1995, 372, 169-172.
140. Cianciotto, N. P.; Fields, B. S. Legionella pneumophila mip gene potentiates intracellular infection of protozoa and human macrophages. Proc. Natl. Acad. Sci. U. S. A., 1992, 89, 5188-5191.
141. Helbig, J. H.; König, B.; Knospe, H.; Bubert, B.; Yu, C.; Lück, C. P.; Riboldi-Tunnicliffe, A.; Hilgenfeld, R.; Jacobs, E.; Hacker, J.; Fischer, G. The PPIase active site of Legionella pneumophila Mip protein is involved in the infection of eukaryotic host cells. Biol. Chem., 2003, 384, 125-137. (Pubitemid 36322638)
142. Wagner, C.; Khan, A. S.; Kamphausen, T.; Schmausser, B.; Unal, C.; Lorenz, U.; Fischer, G.; Hacker, J.; Steinert, M. Collagen binding protein Mip enables Legionella pneumophila to transmigrate through a barrier of NCI-H292 lung epithelial cells and extracellular matrix. Cell. Microbiol., 2007, 9, 450-462. (Pubitemid 46092171)
143. Thai, V.; Renesto, P.; Fowler, C. A.; Brown, D. J.; Davis, T.; Gu, W.; Pollock, D. D.; Kern, D.; Raoult, D.; Eisenmesser, E. Z. Structural, biochemical, and in vivo characterization of the first virally encoded cyclophilin from the Mimivirus. J. Mol. Biol., 2008, 378, 71-86.
144. Limacher, A.; Kloer, D. P.; Flückiger, S.; Folkers, G.; Crameri, R.; Scapozza, L. The crystal structure of Aspergillus fumigatus cyclophilin reveals 3D domain swapping of a central element. Structure, 2006, 14, 185-195. (Pubitemid 43202008)
145. Venugopal, V.; Sen, B.; Datta, A. K.; Banerjee, R. Structure of cyclophilin from Leishmania donovani at 1.97 Å resolution. Acta Crystallogr. F Struct. Biol. Cryst. Commun., 2007, 63, 60-64. (Pubitemid 46276917)
146. Glaser, A. G.; Limacher, A.; Flückiger, S.; Scheynius, A.; Scapozza, L.; Crameri, R. Analysis of the cross-reactivity and of the 1.5 Å crystal structure of the Malassezia sympodialis Mala s 6 allergen, a member of the cyclophilin pan-allergen family. Biochem. J., 2006, 396, 41-49. (Pubitemid 43764495)
147. Peterson, M. R.; Hall, D. R.; Berriman, M.; Nunes, J. A.; Leonard, G. A.; Fairlamb, A. H.; Hunter, W. N. The three-dimensional structure of a Plasmodium falciparum cyclophilin in complex with the potent anti-malarial cyclosporin A. J. Mol. Biol., 2000, 298, 123-133.
148. Vedadi, M.; Lew, J.; Artz, J.; Amani, M.; Zhao, Y.; Dong, A.; Wasney, G. A.; Gao, M.; Hills, T.; Brokx, S.; Qiu, W.; Sharma, S.; Diassiti, A.; Alam, Z.; Melone, M.; Mulichak, A.; Wernimont, A.; Bray, J.; Loppnau, P.; Plotnikova, O.; Newberry, K.; Sundararajan, E.; Houston, S.; Walker, J.; Tempel, W.; Bochkarev, A.; Kozieradzki, I.; Edwards, A.; Arrowsmith, C.; Roos, D.; Kain, K.; Hui, R. Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. Mol. Biochem. Parasitol., 2007, 151, 100-110. (Pubitemid 44911074)
149. Henriksson, L. M.; Johansson, P.; Unge, T.; Mowbray, S. L. X-ray structure of peptidyl-prolyl cis-trans isomerase A from Mycobacterium tuberculosis. Eur. J. Biochem., 2004, 271, 4107-4113. (Pubitemid 39423108)
150. Jin, K. K.; Krishna, S. S.; Schwarzenbacher, R.; McMullan, D.; Abdubek, P. Agarwalla, S.; Ambing, E.; Axelrod, H.; Canaves, J. M.; Chiu, H. J.; Deacon, A. M.; DiDonato, M.; Elsliger, M. A.; Feuerhelm, J.; Godzik, A.; Grittini, C.; Grzechnik, S. K.; Hale, J.; Hampton, E.; Haugen, J.; Hornsby, M.; Jaroszewski, L.; Klock, H. E.; Knuth, M. W.; Koesema, E.; Kreusch, A.; Kuhn, P.; Lesley, S. A.; Miller, M. D.; Moy, K.; Nigoghossian, E.; Okach, L.; Oommachen, S.; Paulsen, J.; Quijano, K.; Reyes, R.; Rife, C.; Stevens, R. C.; Spraggon, G.; van den Bedem, H.; Velasquez, J.; White, A.; Wolf, G.; Han, G. W.; Xu, Q.; Hodgson, K. O.; Wooley, J.; Wilson, I. A. Crystal structure of TM1367 from Thermotoga maritima at 1.90 Å resolution reveals an atypical member of the cyclophilin (peptidylprolyl isomerase) fold. Proteins, 2006, 63, 1112-1118. (Pubitemid 43765164)
151. Taylor, P.; Page, A. P.; Kontopidis, G.; Husi, H.; Walkinshaw, M. D. The X-ray structure of a divergent cyclophilin from the nematode parasite Brugia malayi. FEBS Lett., 1998, 425, 361-366. (Pubitemid 28178922)
152. Dornan, J.; Page, A. P.; Taylor, P.; Wu, S.; Winter, A. D.; Husi, H.; Walkinshaw, M. D. Biochemical and structural characterization of a divergent loop cyclophilin from Caenorhabditis elegans. J. Biol. Chem., 1999, 274, 34877-34883. (Pubitemid 129509534)
153. + to histidine. Angew. Chem. Int. Ed. Engl., 2000, 39, 2931-2934. (Pubitemid 30663828)
154. Wu, S. Y.; Dornan, J.; Kontopidis, G.; Taylor, P.; Walkinshaw, M. D. The first direct determination of a ligand binding constant in protein crystals. Angew. Chem. Int. Ed. Engl., 2001, 40, 582-586. (Pubitemid 32144470)
155. Wear, M. A.; Kan, D.; Rabu, A.; Walkinshaw, M. D. Experimental determination of van der waals energies in a biological system. Angew. Chem. Int. Ed. Engl., 2007, 46, 6453-6456. (Pubitemid 47340170)
156. Picken, N. C.; Eschenlauer, S.; Taylor, P.; Page, A. P.; Walkinshaw, M. D. Structural and biological characterisation of the gut-associated cyclophilin B isoforms from Caenorhabditis elegans. J. Mol. Biol., 2002, 322, 15-25.
157. Clubb, R. T.; Ferguson, S. B.; Walsh, C. T.; Wagner, G. Three-dimensional solution structure of Escherichia coli periplasmic cyclophilin. Biochemistry, 1994, 33, 2761-2772. (Pubitemid 24103333)
158. Konno, M.; Sano, Y.; Okudaira, K.; Kawaguchi, Y.; Yamagishi-Ohmori, Y.; Fushinobu, S.; Matsuzawa, H. Escherichia coli cyclophilin B binds a highly distorted form of trans-prolyl peptide isomer. Eur. J. Biochem., 2004, 271, 3794-3803. (Pubitemid 39233621)
159. Gamble, T. R.; Vajdos, F. F.; Yoo, S.; Worthylake, D. K.; Houseweart, M.; Sundquist, W. I.; Hill, C. P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell, 1996, 87, 1285-1294. (Pubitemid 27010111)
160. Vajdos, F. F.; Yoo, S.; Houseweart, M.; Sundquist, W. I.; Hill, C. P. Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein. Protein Sci., 1997, 6, 2297-2307. (Pubitemid 27490740)
161. Kallen, J.; Mikol, V.; Taylor, P.; Walkinshaw, M. D. X-ray structures and analysis of 11 cyclosporin derivatives complexed with cyclophilin A. J. Mol. Biol., 1998, 283, 435-449. (Pubitemid 28470420)
162. Mikol, V.; Kallen, J.; Walkinshaw, M. D. The X-ray structure of (MeBm2t) 1-cyclosporin complexed with cyclophilin A provides an explanation for its anomalously high immunosuppressive activity. Protein Eng., 1994, 7, 597-603. (Pubitemid 24150068)
163. Papageorgiou, C.; Florineth, A.; Mikol, V Improved binding affinity for cyclophilin A by a cyclosporin derivative singly modified at its effector domain. J. Med. Chem., 1994, 37, 3674-3676. (Pubitemid 24346750)
164. Mikol, V.; Taylor, P.; Kallen, J.; Walkinshaw, M. D. Conformational differences of an immunosuppressant peptolide in a single crystal and in a crystal complex with human cyclophilin A. J. Mol. Biol., 1998, 283, 451-461. (Pubitemid 28470421)
165. Zhao, Y.; Chen, Y.; Schutkowski, M.; Fischer, G.; Ke, H. Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. Structure, 1997, 5, 139-146. (Pubitemid 27102864)
166. Howard, B. R.; Vajdos, F. F.; Li, S.; Sundquist, W. I.; Hill, C. P. Structural insights into the catalytic mechanism of cyclophilin A. Nat. Struct. Biol., 2003, 10, 475-481. (Pubitemid 36637646)
167. Jin, L.; Harrison, S. C. Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin. Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 13522-13526. (Pubitemid 35215414)
168. Mikol, V.; Papageorgiou, C.; Borer, X. The role of water molecules in the structure-based design of (5-hydroxynorvaline)-2-cyclosporin: synthesis, biological activity, and crystallographic analysis with cyclophilin A. J. Med. Chem., 1995, 38, 3361-3367.
169. Sedrani, R.; Kallen, J.; Martin Cabrejas, L. M.; Papageorgiou, CD.; Senia, F.; Rohrbach, S.; Wagner, D.; Thai, B.; Jutzi Eme, A. M.; France, J.; Oberer, L.; Rihs, G.; Zenke, G.; Wagner, J. Sanglifehrin-cyclophilin interaction: degradation work, synthetic macrocyclic analogues, X-ray crystal structure, and binding data. J. Am. Chem. Soc, 2003, 125, 3849-3859. (Pubitemid 36512375)
170. Ottiger, M.; Zerbe, O.; Güntert, P.; Wüthrich, K. The NMR solution conformation of unligated human cyclophilin A. J. Mol. Biol., 1997, 272, 64-81. (Pubitemid 27395538)
171. Zhao, Y.; Ke, H. Crystal structure implies that cyclophilin predominantly catalyzes the trans to cis isomerization. Biochemistry, 1996, 35, 7356-7361. (Pubitemid 26191284)
172. Schiene, C.; Reimer, U.; Schutkowski, M.; Fischer, G. Mapping the stereospecificity of peptidyl prolyl cis/trans isomerases. FEBS Lett, 1998, 432, 202-206. (Pubitemid 28473275)
173. Kontopidis, G.; Taylor, P.; Walkinshaw, M. D. Enzymatic and structural characterization of non-peptide ligand-cyclophilin complexes. Acta Crystallogr. D Biol. Crystallogr, 2004, 60, 479-485. (Pubitemid 41087576)
174. Kallen, J.; Sedrani, R.; Zenke, G.; Wagner, J. Structure of human cyclophilin A in complex with the novel immunosuppressant sanglifehrin A at 1.6 Å resolution. J. Biol. Chem., 2005, 280, 21965-21971. (Pubitemid 40827849)
175. Ke, H. Similarities and differences between human cyclophilin A and other β-barrel structures. Structural refinement at 1.63 Å resolution. J. Mol. Biol., 1992, 228, 539-550. (Pubitemid 23007575)
176. Zhao, Y.; Ke, H. Mechanistic implication of crystal structures of the cyclophilin-dipeptide complexes. Biochemistry, 1996, 35, 7362-7368. (Pubitemid 26189801)
177. Ke, H.; Mayrose, D.; Belshaw, P. J.; Alberg, D. G.; Schreiber, S. L.; Chang, Z. Y.; Etzkorn, FA.; Ho, S.; Walsh, C. T. Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4, 4-dimethylthreonine cyclosporin A. Structure, 1994, 2, 33-44.
178. Lammers, M.; Neumann, H.; Chin, J. W.; James, L. C. Acetylation regulates cyclophilin A catalysis, immunosuppression and HIV isomerisation. Nat. Chem. Biol., 2010, 6, 331-337.
179. Goldstone, D. C.; Yap, M. W.; Robertson, L. E.; Haire, L. F.; Taylor, W. R.; Katzourakis, A.; Stoye, J. P.; Taylor, I. A. Structural and functional analysis of prehistoric lentiviruses uncovers an ancient molecular interface. Cell Host Microbe, 2010, 8, 248-259.
180. Spitzfaden, C.; Braun, W.; Wider, G.; Widmer, H.; Wüthrich, K. Determination of the NMR solution structure of the cyclophilin A-cyclosporin A complex. J. Biomol. NMR, 1994, 4, 463-482.
181. Fraser, J. S.; Clarkson, M. W.; Degnan, S. C.; Erion, R.; Kern, D.; Alber, T. Hidden alternative structures of proline isomerase essential for catalysis. Nature, 2009, 462, 669-673.
182. Konno, M.; Ito, M.; Hayano, T.; Takahashi, N. The substrate-binding site in Escherichia coli cyclophilin A preferably recognizes a cis-proline isomer or a highly distorted form of the trans isomer. J. Mol. Biol., 1996, 256, 897-908. (Pubitemid 26108828)
183. Edwards, K. J.; Ollis, D. L.; Dixon, N. E. Crystal structure of cytoplasmic Escherichia coli pep tidy l-prolyl isomerase: evidence for decreased mobility of loops upon complexation. J. Mol. Biol., 1997, 271, 258-265. (Pubitemid 27344747)
184. Mikol, V.; Kallen, J.; Walkinshaw, M. D. X-ray structure of a cyclophilin B/cyclosporin complex: comparison with cyclophilin A and delineation of its calcineurin-binding domain. Proc. Natl. Acad. Sci. U. S. A., 1994, 91, 5183-5186. (Pubitemid 24177817)
185. Kozlov, G.; Bastos-Aristizabal, S.; Määttänen, P.; Rosenauer, A.; Zheng, F.; Killikelly, A.; Trempe, J. F.; Thomas, D. Y.; Gehring, K. Structural basis of cyclophilin B binding by the calnexin/calreticulin P-domain. J. Biol. Chem., 2010, 285, 35551-35557.
186. Ke, H.; Zhao, Y.; Luo, F.; Weissman, I.; Friedman, J. Crystal structure of murine cyclophilin C complexed with immunosuppressive drug cyclosporin A. Proc. Natl. Acad. Sci. U. S. A., 1993, 90, 11850-11854. (Pubitemid 24008737)
187. Taylor, P.; Dornan, J.; Carrello, A.; Minchin, R. F.; Ratajczak, T.; Walkinshaw, M. D. Two structures of cyclophilin 40: folding and fidelity in the TPR domains. Structure, 2001, 9, 431-438. (Pubitemid 32497270)
188. Wang, T.; Yun, C. H.; Gu, S. Y.; Chang, W. R.; Liang, D. C. 1.88 Å crystal structure of the C domain of hCyP33: a novel domain of peptidyl-prolyl cistrans isomerase. Biochem. Biophys. Res. Commun., 2005, 333, 845-849. (Pubitemid 40854236)
189. Park, S.; Osmers, U.; Raman, G.; Schwantes, R. H.; Diaz, M. O.; Bushweller, J. H. The PHD3 domain of MLL acts as a CYP33-regulated switch between MLL-mediated activation and repression. Biochemistry, 2010, 49, 6576-6586.
190. Wang, Z.; Song, J.; Milne, T. A.; Wang, G. G.; Li, H.; Allis, C. D.; Patel, D. J. Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression. Cell, 2010, 141, 1183-1194.
191. Gourlay, L. J.; Angelucci, F.; Baiocco, P.; Boumis, G.; Brunori, M.; Bellelli, A.; Miele, A. E. The three-dimensional structure of two redox states of cyclophilin A from Schistosoma mansoni. Evidence for redox regulation of peptidyl-prolyl cis-trans isomerase activity. J. Biol. Chem., 2007, 282, 24851-24857. (Pubitemid 47347521)
192. Schlatter, D.; Thoma, R.; Küng, E.; Stihle, M.; Müller, F.; Borroni, E.; Cesura, A.; Hennig, M. Crystal engineering yields crystals of cyclophilin D diffracting to 1.7 Å resolution. Acta Crystallogr. D Biol. Crystallogr., 2005, 61, 513-519. (Pubitemid 44336722)
193. Kajitani, K.; Fujihashi, M.; Kobayashi, Y.; Shimizu, S.; Tsujimoto, Y.; Miki, K. Crystal structure of human cyclophilin D in complex with its inhibitor, cyclosporin A at 0.96-Å resolution. Proteins, 2008, 70, 1635-1639. (Pubitemid 351304121)
194. Stegmann, C. M.; Seeliger, D.; Sheldrick, G. M.; de Groot, B. L.; Wahl, M. C. The thermodynamic influence of trapped water molecules on a protein-ligand interaction. Angew. Chem. Int. Ed. Engl., 2009, 48, 5207-5210.
195. Reidt, U.; Wahl, M. C.; Fasshauer, D.; Horowitz, D. S.; Lührmann, R.; Ficner, R. Crystal structure of a complex between human spliceosomal cyclophilin H and a U4/U6 snRNP-60K peptide. J. Mol. Biol., 2003, 331, 45-56. (Pubitemid 36870776)
196. Reidt, U.; Reuter, K.; Achsel, T.; Ingelfinger, D.; Lührmann, R.; Ficner, R. Crystal structure of the human U4/U6 small nuclear ribonucleoprotein particle-specific SnuCyp-20, a nuclear cyclophilin. J. Biol. Chem., 2000, 275, 7439-7442. (Pubitemid 30159633)
197. Huang, L. L.; Zhao, X. M.; Huang, C. Q.; Yu, L.; Xia, Z. X. Structure of recombinant human cyclophilin J, a novel member of the cyclophilin family. Acta Crystallogr. D Biol. Crystallogr., 2005, 61, 316-321. (Pubitemid 43965373)
198. Thériault, Y.; Logan, T. M.; Meadows, R.; Yu, L.; Olejniczak, E. T.; Holzman, T. F.; Simmer, R. L.; Fesik, S. W. Solution structure of the cyclosporin A/cyclophilin complex by NMR. Nature, 1993, 361, 88-91. (Pubitemid 23020781)
199. Pflügl, G.; Kallen, J.; Schirmer, T.; Jansonius, J. N.; Zurini, M. G.; Walkinshaw, M. D. X-ray structure of a decameric cyclophilin-cyclosporin crystal complex. Nature, 1993, 361, 91-94. (Pubitemid 23020782)
200. Luban, J.; Bossolt, K. L.; Franke, E. K.; Kalpana, G. V.; Goff, S. P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell, 1993, 73, 1067-1078. (Pubitemid 23180482)
201. Zander, K.; Sherman, M. P.; Tessmer, U.; Bruns, K.; Wray, V.; Prechtel, A. T.; Schubert, E.; Henklein, P.; Luban, J.; Neidleman, J.; Greene, W. C.; Schubert, U. Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression. J. Biol. Chem., 2003, 278, 43202-43213. (Pubitemid 37345939)
202. Votteler, J.; Studtrucker, N.; Sörgel, S.; Münch, J.; Rücker, E.; Kirchhoff, F.; Schick, B.; Henklein, P.; Fossen, T.; Bruns, K.; Sharma, A.; Wray, V.; Schubert, U. Proline 35 of human immunodeficiency virus type 1 (HIV-1) Vpr regulates the integrity of the N-terminal helix and the incorporation of Vpr into virus particles and supports the replication of R5-tropic HIV-1 in human lymphoid tissue ex vivo. J. Virol., 2007, 81, 9572-9576. (Pubitemid 47311503)
203. Daelemans, D.; Dumont, J. M.; Rosenwirth, B.; De Clercq, E.; Pannecouque, C. Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle. Antiviral Res., 2010, 85, 418-421.
204. Luban, J. Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions. Cell, 1996, 87, 1157-1159. (Pubitemid 27010099)
205. Strebel, K.; Luban, J.; Jeang, K. T. Human cellular restriction factors that target HIV-1 replication. BMC Med., 2009, 7, 48.
206. Li, Y.; Kar, A. K.; Sodroski, J. Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A. J. Virol., 2009, 83, 10951-10962.
207. Nisole, S.; Lynch, C.; Stoye, J. P.; Yap, M. W. A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 13324-13328. (Pubitemid 39209664)
208. Bosco, D. A.; Eisenmesser, E. Z.; Pochapsky, S.; Sundquist, W. I.; Kern, D. Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A. Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 5247-5252. (Pubitemid 34411534)
209. Vahlne, A.; Larsson, P. A.; Horal, P.; Ahlmen, J.; Svennerholm, B.; Gronowitz, J. S.; Olofsson, S. Inhibition of herpes simplex virus production in vitro by cyclosporin A. Arch. Virol., 1992, 122, 61-75.
210. Bose, S.; Mathur, M.; Bates, P.; Joshi, N.; Banerjee, A. K. Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype. J. Gen. Virol., 2003, 84, 1687-1699. (Pubitemid 36805903)
211. Watashi, K.; Hijikata, M.; Hosaka, M.; Yamaji, M.; Shimotohno, K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology, 2003, 38, 1282-1288. (Pubitemid 37314838)
212. Inoue, K.; Yoshiba, M. Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease. Transplant. P roc., 2005, 37, 1233-1234. (Pubitemid 40590846)
213. Ma, S.; Boerner, J. E.; TiongYip, C.; Weidmann, B.; Ryder, N. S.; Cooreman, M. P.; Lin, K. NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon. Antimicrob. Agents Chemother., 2006, 50, 2976-2982. (Pubitemid 44396401)
214. Landrieu, I.; Hanoulle, X.; Bonachera, F.; Hamel, A.; Sibille, N.; Yin, Y.; Wieruszeski, J. M.; Horvath, D.; Wei, Q.; Vuagniaux, G.; Lippens, G. Structural basis for the non-immunosuppressive character of the cyclosporin A analogue Debio 025. Biochemistry, 2010, 49, 4679-4686.
215. Hopkins, S.; Scorneaux, B.; Huang, Z.; Murray, M. G.; Wring, S.; Smitley, C.; Harris, R.; Erdmann, F.; Fischer, G.; Ribeill, Y. SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro. Antimicrob. Agents Chemother., 2010, 54, 660-672.
216. Shavinskaya, A.; Boulant, S.; Penin, F.; McLauchlan, J.; Bartenschlager, R. The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J. Biol. Chem., 2007, 282, 37158-37169.
217. Fernandes, F.; Poole, D. S.; Hoover, S.; Middleton, R.; Andrei, A. C.; Gerstner, J.; Striker, R. Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B. Hepatology, 2007, 46, 1026-1033. (Pubitemid 350144767)
218. Robida, J. M.; Nelson, H. B.; Liu, Z.; Tang, H. Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro. J. Virol., 2007, 81, 5829-5840. (Pubitemid 46847020)
219. Watashi, K.; Ishii, N.; Hijikata, M.; Inoue, D.; Murata, T.; Miyanari, Y.; Shimotohno, K. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol. Cell, 2005, 19, 111-122. (Pubitemid 40884662)
220. Hanoulle, X.; Badillo, A.; Wieruszeski, J. M.; Verdegem, D.; Landrieu, I.; Bartenschlager, R.; Penin, F.; Lippens, G. Hepatitis C virus NS5A protein is a substrate for the peptidyl-prolyl cis/trans isomerase activity of cyclophilins A and B. J. Biol. Chem., 2009, 284, 13589-13601.
221. Nakagawa, M.; Sakamoto, N.; Tanabe, Y.; Koyama, T.; Itsui, Y.; Takeda, Y.; Chen, C. H.; Kakinuma, S.; Oooka, S.; Maekawa, S.; Enomoto, N.; Watanabe, M. Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins. Gastroenterology, 2005, 129, 1031-1041. (Pubitemid 41242693)
222. Yang, F.; Robotham, J. M.; Nelson, H. B.; Irsigler, A.; Kenworthy, R.; Tang, H. Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro. J. Virol., 2008, 82, 5269-5278. (Pubitemid 351705235)
223. Kaul, A.; Stauffer, S.; Berger, C.; Pertel, T.; Schmitt, J.; Kallis, S.; Zayas, M.; Lohmann, V.; Luban, J.; Bartenschlager, R. Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics. PLoS Pathog., 2009, 5, e1000546.
224. Billich, A.; Winkler, G.; Aschauer, H.; Rot, A.; Peichl, P. Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis. J. Exp. Med., 1997, 185, 975-980. (Pubitemid 27119882)
225. Yurchenko, V.; O'Connor, M.; Dai, W. W.; Guo; H.; Toole, B.; Sherry, B.; Bukrinsky, M. CD147 is a signaling receptor for cyclophilin B. Biochem. Biophys. Res. Commun., 2001, 288, 786-788. (Pubitemid 33140950)
226. Yurchenko, V.; Zybarth, G.; O'Connor, M.; Dai, W. W.; Franchin, G.; Hao, T.; Guo, H.; Hung, H. C.; Toole, B.; Gallay, P.; Sherry, B.; Bukrinsky, M. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J. Biol. Chem., 2002, 277, 22959-22965. (Pubitemid 34967280)
227. Yurchenko, V.; Constant, S.; Bukrinsky, M. Dealing with the family: CD147 interactions with cyclophilins. Immunology, 2006, 117, 301-309.
228. Arora, K.; Gwinn, W. M.; Bower, M. A.; Watson, A.; Okwumabua, I.; MacDonald, H. R.; Bukrinsky, M. I.; Constant, S. L. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J. Immunol., 2005, 175, 517-522. (Pubitemid 40884357)
229. Gwinn, W. M.; Damsker, J. M.; Falahati, R.; Okwumabua, I.; Kelly-Welch, A.; Keegan, A. D.; Vanpouille, C.; Lee, J. J.; Dent, L. A.; Leitenberg, D.; Bukrinsky, M. I.; Constant, S. L. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. J. Immunol., 2006, 177, 4870-4879. (Pubitemid 44469823)
230. Wang, L.; Wang, C. H.; Jia, J. F.; Ma, X. K.; Li, Y.; Zhu, H. B.; Tang, H.; Chen, Z. N.; Zhu, P. Contribution of cyclophilin A to the regulation of inflammatory processes in rheumatoid arthritis. J. Clin. Immunol., 2010, 30, 24-33.
231. Tegeder, I.; Schumacher, A.; John, S.; Geiger, H.; Geisslinger, G.; Bang, H.; Brune, K. Elevated serum cyclophilin levels in patients with severe sepsis. J. Clin. Immunol., 1997, 17, 380-386. (Pubitemid 27431977)
232. Satoh, K.; Matoba, T.; Suzuki, J.; O'Dell, M. R.; Nigro, P.; Cui, Z.; Mohan, A.; Pan, S.; Li, L.; Jin, Z. G.; Yan, C.; Abe, J.; Berk, B. C. Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation. Circulation, 2008, 117, 3088-3098.
233. Schlegel, J.; Redzic, J. S.; Porter, C. C.; Yurchenko, V.; Bukrinsky, M.; Labeikovsky, W.; Armstrong, G. S.; Zhang, F.; Isern, N. G.; DeGregori, J.; Hodges, R.; Eisenmesser, E. Z. Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A. J. Mol. Biol., 2009, 391, 518-535.
234. Song, F.; Zhang, X.; Ren, X. B.; Zhu, P.; Xu, J.; Wang, L.; Li, Y. F.; Zhong, N.; Ru, Q.; Zhang, D. W.; Jiang, J. L.; Xia, B.; Chen, Z. N. Cyclophilin A (CyPA) induces chemotaxis independent of its peptidyl-prolyl cis-trans isomerase activity: direct binding between CyPA and the ectodomain of CD147. J. Biol. Chem., 2011, 286, 8197-8203.
235. Obchoei, S.; Wongkhan, S.; Wongkham, C.; Li, M.; Yao, Q.; Chen, C. Cyclophilin A: potential functions and therapeutic target for human cancer. Med. Sci. Monit., 2009, 15, RA221-232.
236. Lee, J. Novel combinational treatment of cisplatin with cyclophilin A inhibitors in human heptocellular carcinomas. Arch. Pharmacal Res., 2010, 33, 1401-1409.
237. Choi, K. J.; Piao, Y. J.; Lim, M. J.; Kim, J. H.; Ha, J.; Choe, W.; Kim, S. S. Overexpressed cyclophilin A in cancer cells renders resistance to hypoxiaand cisplatin-induced cell death. Cancer Res., 2007, 67, 3654-3662. (Pubitemid 46762150)
238. Lee, J.; Kim, S. S. An overview of cyclophilins in human cancers. J. Int. Med. Res., 2010, 38, 1561-1574.
239. Baum, N.; Schiene-Fischer, C.; Frost, M.; Schumann, M.; Sabapathy, K.; Ohlenschläger, O.; Grosse, F.; Schlott, B. The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis. Oncogene, 2009, 28, 3915-3925.
240. Bauer, K.; Kretzschmar, A. K.; Cvijic, H.; Blumert, C.; Löffler, D.; Brocke-Heidrich, K.; Schiene-Fischer, C.; Fischer, G.; Sinz, A.; Clevenger, C. V.; Horn, F. Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells. Oncogene, 2009, 28, 2784-2795.
241. Pan, H.; Luo, C.; Li, R.; Qiao, A.; Zhang, L.; Mines, M.; Nyanda, A. M.; Zhang, J.; Fan, G. H. Cyclophilin A is required for CXCR4-mediated nuclear export of heterogeneous nuclear ribonucleoprotein A2, activation and nuclear translocation of ERK1/2, and chemotactic cell migration. J. Biol. Chem., 2008, 283, 623-637.
242. Periyasamy, S.; Hinds, T. Jr.; Shemshedini, L.; Shou, W.; Sanchez, E. R. FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A. Oncogene, 2010, 29, 1691-1701.
243. Chen, J.; Watanabe, M.; Huang, P.; Sakaguchi, M.; Ochiai, K.; Nasu, Y.; Ouchida, M.; Huh, N. H.; Shimizu, K.; Kashiwakura, Y.; Kaku, H.; Kumon, H. REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells. Int. J. Mol. Med., 2009, 24, 789-794.
244. Obama, K.; Kato, T.; Hasegawa, S.; Satoh, S.; Nakamura, Y.; Furukawa, Y. Overexpression of peptidyl-prolyl isomerase-like 1 is associated with the growth of colon cancer cells. Clin. Cancer Res., 2006, 12, 70-76. (Pubitemid 43166178)
245. Crompton, M.; Virji, S.; Ward, J. M. Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur. J. Biochem., 1998, 258, 729-735. (Pubitemid 28557940)
246. Halestrap, A. P.; Woodfield, K. Y.; Connern, C. P. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J. Biol. Chem., 1997, 272, 3346-3354.
247. Baines, C. P.; Kaiser, R. A.; Purcell, N. H.; Blair, N. S.; Osinska, H.; Hambleton, M. A.; Brunskill, E. W.; Sayen, M. R.; Gottlieb, R. A.; Dorn, G. W.; Robbins, J.; Molkentin, J. D. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature, 2005, 434, 658-662. (Pubitemid 40488559)
248. Nakagawa, T.; Shimizu, S.; Watanabe, T.; Yamaguchi, O.; Otsu, K.; Yamagata, H.; Inohara, H.; Kubo, T.; Tsujimoto, Y. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature, 2005, 434, 652-658. (Pubitemid 40488558)
249. Schinzel, A. C.; Takeuchi, O.; Huang, Z.; Fisher, J. K.; Zhou, Z.; Rubens, J.; Hetz, C.; Danial, N. N.; Moskowitz, M. A.; Korsmeyer, S. J. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A., 2005, 102, 12005-12010. (Pubitemid 41291119)
250. Du, H.; Guo, L.; Fang, F.; Chen, D.; Sosunov, A. A.; McKhann, G. M.; Yan, Y.; Wang, C.; Zhang, H.; Molkentin, J. D.; Gunn-Moore, F. J.; Vonsattel, J. P.; Arancio, O.; Chen, J. X.; Yan, S. D. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat. Med., 2008, 14, 1097-1105.
251. Forte, M.; Gold, B. G.; Marracci, G.; Chaudhary, P.; Basso, E.; Johnsen, D.; Yu, X.; Fowlkes, J.; Rahder, M.; Stem, K.; Bernardi, P.; Bourdette, D. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 7558-7563. (Pubitemid 47185945)
252. Barik, S. Immunophilins: for the love of proteins. Cell. Mol. Life Sci., 2006, 63, 2889-2900. (Pubitemid 46072296)